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Summary
The solubility of phenytoin in binary mixtures of ethanol + water at 298.2 K in 
the presence of three different concentrations of sodium dodecyl sulfate (sds) was 
reported. The Jouyban-Acree model was used for correlating the generated data and 
the obtained mean relative deviation was 7.3%. When all data points of phenytoin in 
binary solvents at various sds concentrations were fitted to the model, the obtained 
mean relative deviation was 10.1%.
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Resumen
Solubilidad de la fenitoína en mezclas acuosas de etanol 
y dodecil-sulfato sódico a 298 K
Se presenta la solubilidad de la fenitoína a 298,2 K en mezclas binarias de etanol y 
agua en presencia de tres diferentes concentraciones de dodecil-sulfato sódico (dss). 
Se utiliza el modelo de Jouyban-Acree para correlacionar los datos generados obte-
niendo una desviación media relativa de 7,3%. Al ajustar al modelo todos los datos 
obtenidos de la fenitoína en los solventes binarios y en las diferentes concentraciones 
de dss la desviación media relativa obtenida fue de 10,1%. 
Palabras clave: solubilidad, fenitoína, etanol, mezcla solvente, dodecil-sulfato sódico, 
modelo de Jouyban-Acree.
Introduction
Poor aqueous solubility of drugs is an obstacle in drug discovery and development 
investigations. As a general rule, poorly water soluble drugs possess low bioavailability. 
Unfortunately, nearly 70% of new drug candidates are low water soluble compounds 
[1]. In addition, low solubility makes a number of problems in preparation of liquid 
formulations of drugs and also their bioavailability. Various techniques have been used 
to solve this problem including salt formation, prodrugs, preparation of cocrystals, etc. 
[2-5]. Solubilization techniques including cosolvency [6] and addition of surfactants 
[7] are also used to solubilize poorly soluble drugs. In addition to the individual appli-
cation of cosolvents [8-11] and surfactants [12, 13], their combined forms are also 
employed in the pharmaceutical investigations [14, 15] for solubilization of drugs.
Phenytoin (see Figure 1 for chemical structure) is an anti-epileptic drug, which is 
used in the therapeutics. It is an acidic drug with the pKa of 8.33 and the aqueous 
solubility of 7.53  10-5 M [16]. Its salt formations with piperazine, piperidine, 
ethylenediamine, ethanolamine and sodium were increased the solubility by factors 
of 59, 418, 468, 507 and 3617 [17]. The solubility of phenytoin was investigated in 
aqueous solutions of cyclodextrins [18], aqueous mixtures of 1,3-butanediol, ethanol, 
glycerine, methanol, polyethylene glycol (PEG) 200, PEG 400, propylene glycol and 
sorbitol at 298 K [19]. 
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Figure 1. Chemical structure of phenytoin.
To extend our systematic investigations on the solubility of drugs in mixed solvents, the 
solubility of phenytoin in binary mixtures of ethanol + water at 298.2 K in the absence 
of sodium dodecyl sulfate (sds) and in the presence of three different concentrations 
of sds was reported and the produced data was mathematically represented by the 
Jouyban-Acree model. sds at concentrations above its critical micelle concentrations 
could form micelles and increase the solubility of hydrophobic drugs by partitioning 
process. We used lower concentrations of sds in this work, and no micelles will be 
formed in the investigated aqueous and also mixed solvent or non-aqueous solutions. 
Computational method
Among several mathematical models for calculating the solubility of drugs in mixed 
solvents [20], the log-linear model of Yalkowsky [21] is the simplest model and the 
Jouyban-Acree model is the most accurate model [20, 22]. The Jouyban-Acree model 
was proposed for representing solvent composition and temperature effects on the 
solubility of drugs in mixed solvents with the general form of [23]:
log .log .log
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in which Cm T
sat
,  is the solute solubility in the solvent mixtures at temperature T (Kel-
vin), 1 and 2 are the volume fractions of the solvents 1 and 2, respectively, C T
sat
1,  and 
C T
sat
2,  are the solubility of the solute in the mono-solvents 1 and 2, respectively, and Ji 
are the constants of the model computed by regression analysis [24]. In this work, one 
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could consider ethanol + sds (in various concentrations) as solvent 1 and water + sds 
as solvent 2.
To evaluate the accuracy of the computations, the mean relative deviation (mrd) 





















where N was the number of data points in each set. 
Materials and methods
Materials
Phenytoin was purchased from Alhavi Pharmaceutical company (Tehran, Iran). Etha-
nol (99.8%) and sds (purity of 99.0%) were purchased from Merck (Germany), and 
double distillated water was used for preparation of the solutions. Ethanol with purity 
of 96% v/v (or 93.5% m/m) was used for dilution of saturated solutions prior to spec-
trophotometric analyses of the samples. 
Preparation of the solvent mixtures
Various concentrations of sds, i.e. 1.6  10-3, 3.2  10-3 and 6.4  10-3 mol·L-1, were 
prepared in water and/or ethanol, then all binary solvent mixtures were made by mix-
ing appropriate volume fractions of the solvents (with or without sds) by uncertainty 
of 0.1 mL with the total volume of 30 mL. 
Solubility determination
Various solubility determination methods were used in the literature which was 
reviewed in a recent work [25] and the saturation shake-flask method of Higuchi and 
Connors [26] was used in this work. The solubility was determined by equilibrating 
excess amounts of drugs in the prepared solvent systems using a shaker (Behdad, Teh-
ran, Iran) placed in an incubator equipped with a temperature-controlling system at 
different temperatures with the uncertainty of 0.2 K (Kimia Idea Pardaz Azarbayjan 
—kipa—, Tabriz, Iran) for 3 days to reach the equilibrium at 298.2 K. The saturated 
solutions were centrifuged at 13,000 rpm for 15 minutes (mse Micro Center MSB010.
CX2.5, Sanyo, Japan) and after diluting with ethanol (96% v/v), the absorbance of 
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these solutions were recorded at 220 nm using a UV-vis spectrophotometer (Biotech-
Ultraspec 2000, England). Concentrations of the diluted solutions were determined 
by measuring the UV absorbance. Each experimental data is an average of at least three 
experimental measurements, and the mean relative standard deviation (rsd) of three 
repetitive experiments is 2.3%.
Results and discussions
Table 1 lists the volume fractions of ethanol + water, concentrations of sds and the 
experimental molar solubilities of phenytoin. There are good agreements between 
measured aqueous solubilities of phenytoin and the reported values in the literature 
[16, 19]. In addition to aqueous solubility data, the solubility profile of phenytoin in 
ethanol + water mixtures at 298 K is in agreement with that reported by Rubino and 
his coworkers [19] as graphically represented in Figure 2. The minimum solubility is 
observed in aqueous solution (8.00  10-5 mol·L-1) and the maximum solubility is 
observed in ethanol (1  = 0.90) and sds of 6.4  10-3 mol·L-1 (5.72  10-5 mol·L-1), 
revealing that addition of ethanol and sds to the aqueous solutions make the solu-
bility enhancement by a factor of 7149. The enhancement factor of sds (6.4  10-3 
mol·L-1) for aqueous solution in the absence of ethanol is 47 and that of ethanol (1  = 
0.90) in the absence of sds is 768. These observations reveal that there is a synergistic 
effect on the solubility of phenytoin when ethanol and sds are added simultaneously 
to the aqueous solutions. It should be added that the monomeric sds molecules act as 
a secondary cosolvent and no micelles are formed in the investigated concentrations 
of sds.
Solubility data of each concentration of sds was fitted to Eq. (1) and the model con-
stants were computed using least square analysis. Then the solubilities were back-calcu-
lated and the mrd values were computed using Eq. (2). These values are listed in Table 2. 
When all solubility data of phenytoin in different concentration of sds was fitted to 
Eq. (1), the obtained model was:
log .log .log
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Equation (3) back-calculated the solubility of phenytoin with the mrd values of 10.1% 
(N = 44). When the model was trained using a minimum number of experimental 
solubility data at the highest and lowest sds concentrations and ethanol fractions of 
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Table 1. Experimental molar solubility Cm T
Sat
,( )  of phenytoin in various volume fractions 1( )  of 
ethanol (1) + water (2) mixtures and different concentrations of sds at 298.2 K.
1 Without sds 
sds 1.6  10-3 
mol·L-1
sds 3.2  10-3 
mol·L-1
sds 6.4  10-3 
mol·L-1
0.00 8.00  10-5 2.50  10-3 2.87  10-3 3.76  10-3
0.10 1.50  10-4 2.53  10-3 3.63  10-3 4.22  10-3
0.20 3.30  10-4 8.96  10-3 1.12  10-2 1.19  10-2
0.30 9.90  10-4 1.85  10-2 2.15  10-2 2.26  10-2
0.40 3.48  10-3 3.69  10-2 4.60  10-2 4.95  10-2
0.50 9.63  10-3 9.85  10-2 1.15  10-1 1.41  10-1
0.60 2.05  10-2 2.05  10-1 2.38  10-1 3.62  10-1
0.70 3.48  10-2 3.30  10-1 3.83  10-1 4.21  10-1
0.80 4.96  10-2 3.94  10-1 4.59  10-1 5.35  10-1
0.90 6.14  10-2 4.74  10-1 5.51  10-1 5.72  10-1
1.00 5.87  10-2 4.12  10-1 4.79  10-1 4.91  10-1
Figure 2. Molar solubilities of phenytoin (our data and reported data in an earlier work [19]).
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0.00, 0.30, 0.50, 0.70 and 1.00 and the rest of data points were predicted, the obtained 
mrd is 13.9% (N = 34) which is an acceptable error range considering the similar 
predictions in the pharmaceutical area. This equation could represent the non-ideal 
mixing of aqueous and ethanolic solutions of phenytoin in the absence and presence of 
sds. The effects of various concentrations of sds in ethanol + water mixtures could be 
partially represented in the numerical values of  C T
sat




Experimental solubility of phenytoin is reported in aqueous binary mixtures of etha-
nol and three different concentrations of sds, which extended the available solubility 
database of pharmaceuticals in mixed solvents [27]. The Jouyban-Acree model fits well 
to the experimental solubility data of phenytoin at all composition ranges of solvent 
mixtures. These findings are supported by acceptable mrd values of the calculated and 
experimental solubility data. 
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